01. Executive Summary 02. Scope of the Report 02.1 Market Overview 02.2 Product Offerings 03. Market Research Methodology 03.1 Market Research Process 03.2 Research Design 03.3 Research Methodology 04. List of Abbreviations 05. Introduction 06. Market Landscape 06.1 Market Overview 07. Global MicroRNA Research Market 08. Global MicroRNA Market 08.1 Market Size and Forecast 08.2 Five Forces Analysis 09. Global MicroRNA Market Segmentation 09.1 Global MicroRNA Tools and Reagents Market 09.1.1 Market Size and Forecast 09.2 Global MicroRNA Therapeutics Market 09.2.1 Market Size and Forecast 09.3 Global MicroRNA Diagnostics Market 09.3.1 Market Size and Forecast 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 18.1 Competitive Scenario 18.1.1 Key News 18.2 Key Vendor Ranking 2012 18.3 Other Prominent Vendors 19. Key Vendor Analysis 19.1 Alnylam Pharmaceuticals Inc. 19.1.1 Business Overview 19.1.2 Business Segmentation 19.1.3 Key Information 19.1.4 SWOT Analysis 19.2 Exiqon A/S 19.2.1 Business Overview 19.2.2 Business Segmentation 19.2.3 Key Information 19.2.4 SWOT Analysis 19.3 Santaris Pharma A/S 19.3.1 Business Overview 19.3.2 Business Segmentation 19.3.3 Key Information 19.3.4 SWOT Analysis 20. Other Reports in this Series List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Market Segmentation Exhibit 3: Market Segmentation by Geography Exhibit 4: MicroRNA Research Publications Exhibit 5: Models Employed for MicroRNA Research Exhibit 6: Areas with MicroRNA Research Exhibit 7: Global MicroRNA Market 2012-2016 (US$ million) Exhibit 8: Global MicroRNA Market Segmentation Exhibit 9: Global MicroRNA Market Segmentation 2012 Exhibit 10: Global MicroRNA Market Segmentation 2012-2016 Exhibit 11: Global MicroRNA Tools and Reagents Market 2012-2016 (US$ million) Exhibit 12: Global MicroRNA Expression Profiling Market Segmentation by Type of Technology Exhibit 13: Global MicroRNA Tools and Reagents Market Segmentation by Geography Exhibit 14: Global MicroRNA Therapeutics Market 2012-2016 (US$ million) Exhibit 15: Global MicroRNA Diagnostics Market 2012-2016 (US$ million) Exhibit 16: Global MicroRNA Market Segmentation by Geography 2012 Exhibit 17: Business Segmentation of Alnylam Pharmaceuticals Inc. Exhibit 18: Business segmentation of Exiqon A/S Exhibit 19: Business Segmentation of Santaris Pharma A/S

Alnylam Pharmaceuticals Inc., Exiqon A/S, Santaris Pharma A/S., Access Pharmaceuticals, Aegera Therapeutics Inc., Affymetrix Inc., Agilent Technologies, Antisense Pharma GmbH, Aparna Biosciences Corp., Applied Biological Materials Inc., Arrowhead Research Corp., AstraZeneca Pharmaceuticals LP, Asuragen Inc., Benitec Biopharma Ltd., BioCancell Therapeutics Inc., Biogen Idec Inc., CBC Comprehensive Biomarker Center GmbH, Clontech Laboratories Inc., Dicerna Pharmaceuticals Inc., Eli Lilly and Co., EMD4Biosciences, Expression Genetics Inc., F. Hoffman-La Roche AG, Fluidigm Corp., GeneCopoeia Inc., GenoSensor Corp., Gensignia Inc., Groove Biopharma, GlaxoSmithKline, HTG Molecular Diagnostics Inc., Idera Pharmaceuticals Inc., Illumina Inc., InteRNA Technologies B.V., Isis Pharmaceuticals Inc., LC Sciences Llc, Life Technologies Corp., Merck & Co. Inc., miRagen Therapeutics Inc., Mirna Therapeutics Inc., NanoString Technologies Inc., Norgen Biotek Corp., Novartis AG, Pfizer Inc., Phalanx Biotech Group, PhaseRx Inc., Prolias Technologies Inc., Qiagen N.V., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Rosetta Genomics Ltd., RXi Pharmaceuticals Corp., Sanofi U.S., Sarepta Therapeutics, Sigma-Aldrich Co. Llc, Silence Therapeutics Plc, Sirnaomics Inc., siRNAsense AS, Sylentis SA, Tacere Therapeutics Inc., Tekmira Pharmaceuticals Corp., Theradiag, Thermo Fisher Scientific Inc., and WaferGen Biosystems Inc.